SlideShare a Scribd company logo
1 of 1
Download to read offline
in 10 charts
Among the 58 therapeutic companies ...
The 2014 US biotech IPO market
Therapeutic | 58
Diagnostic | 5
Licensed | 26%
Q2 Q3 Q4
Therapeutic
Molecular diagnostic
Retained
rights | 74%
Of the 63 IPOs, over 92% were therapeutic companies
US biotechs in 2014 not only set a
record for number of IPOs ...
... but also set a record for IPO proceeds,
nearing US$5 billion
Only 31% of therapeutic companies were
in Phase III or later
By 31 December, stocks were up by 42%
relative to their IPO prices …
Nearly 60% were priced within or above their
expected ranges
... while only 26% had licensed their
lead product to a larger company
26+74+J
Oncology | 14 CNS | 7
Infection | 6
Renal | 6
Endocrinology | 5
Ophthalmic | 5
Other | 15
24% were primarily
in oncology ...
24+12+10+10+9+9+26+J
Phase II | 32
Phase I | 5
Pre-clinical | 3
Marketed | 3
Phase III | 15
... 55% were
in Phase II ...
55+26+5+5+9+J
H1 H2
Compiled by EY Global Life Sciences Center (@EY_LifeSciences) using data from 28 years of EY biotechnology annual reports. For more data, trends and implications,
download our thought leadership at ey.com/lifesciences or join the conversation on our blog (lifesciencesblog.ey.com).
92+8+J
Phase III or marketed Phase II or earlier
Within or above Below range
Q1
2000 52
412013
2005 17
282004
242006
222007
2014 63 2014 $4.9b
2000 $4.5b
2013 $3.3b
2004 $1.6b
2007 $1.2b
2006 $1.1b
2010 $1.1b
Q2
Q3
Q4
34%
49%
-33%
16%
70%
52%
43%
25%66% 75%
0%
0%
20%
20%
-20%
-40%
40%
40%
60%
60%80%
… with therapeutic outperforming diagnostic
Q1
73% 23 total IPOs
17 total IPOs
13 total IPOs
10 total IPOs
27%
38% 62%
54% 46%
60% 40%

More Related Content

More from EY

EY Price Point: global oil and gas market outlook, Q2 | April 2022
EY Price Point: global oil and gas market outlook, Q2 | April 2022EY Price Point: global oil and gas market outlook, Q2 | April 2022
EY Price Point: global oil and gas market outlook, Q2 | April 2022EY
 
EY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlookEY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlookEY
 
EY Price Point: global oil and gas market outlook, Q2 April 2021
EY Price Point: global oil and gas market outlook, Q2 April 2021EY Price Point: global oil and gas market outlook, Q2 April 2021
EY Price Point: global oil and gas market outlook, Q2 April 2021EY
 
Tax Alerte - Principales dispositions loi de finances 2021
Tax Alerte - Principales dispositions loi de finances 2021Tax Alerte - Principales dispositions loi de finances 2021
Tax Alerte - Principales dispositions loi de finances 2021EY
 
EY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlookEY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlookEY
 
Tax Alerte - prix de transfert - PLF 2021
Tax Alerte - prix de transfert - PLF 2021Tax Alerte - prix de transfert - PLF 2021
Tax Alerte - prix de transfert - PLF 2021EY
 
EY Price Point: global oil and gas market outlook (Q4, October 2020)
EY Price Point: global oil and gas market outlook (Q4, October 2020)EY Price Point: global oil and gas market outlook (Q4, October 2020)
EY Price Point: global oil and gas market outlook (Q4, October 2020)EY
 
EY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlookEY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlookEY
 
Zahl der Gewinnwarnungen steigt auf Rekordniveau
Zahl der Gewinnwarnungen steigt auf RekordniveauZahl der Gewinnwarnungen steigt auf Rekordniveau
Zahl der Gewinnwarnungen steigt auf RekordniveauEY
 
Versicherer rechnen mit weniger Neugeschäft
Versicherer rechnen mit weniger NeugeschäftVersicherer rechnen mit weniger Neugeschäft
Versicherer rechnen mit weniger NeugeschäftEY
 
Liquidity for advanced manufacturing and automotive sectors in the face of Co...
Liquidity for advanced manufacturing and automotive sectors in the face of Co...Liquidity for advanced manufacturing and automotive sectors in the face of Co...
Liquidity for advanced manufacturing and automotive sectors in the face of Co...EY
 
IBOR transition: Opportunities and challenges for the asset management industry
IBOR transition: Opportunities and challenges for the asset management industryIBOR transition: Opportunities and challenges for the asset management industry
IBOR transition: Opportunities and challenges for the asset management industryEY
 
Fusionen und Übernahmen dürften nach der Krise zunehmen
Fusionen und Übernahmen dürften nach der Krise zunehmenFusionen und Übernahmen dürften nach der Krise zunehmen
Fusionen und Übernahmen dürften nach der Krise zunehmenEY
 
Start-ups: Absturz nach dem Boom?
Start-ups: Absturz nach dem Boom?Start-ups: Absturz nach dem Boom?
Start-ups: Absturz nach dem Boom?EY
 
EY Price Point: global oil and gas market outlook, Q2, April 2020
EY Price Point: global oil and gas market outlook, Q2, April 2020EY Price Point: global oil and gas market outlook, Q2, April 2020
EY Price Point: global oil and gas market outlook, Q2, April 2020EY
 
Riding the crest of digital health in APAC
Riding the crest of digital health in APACRiding the crest of digital health in APAC
Riding the crest of digital health in APACEY
 
EY Chemical Market Outlook - February 2020
EY Chemical Market Outlook - February 2020EY Chemical Market Outlook - February 2020
EY Chemical Market Outlook - February 2020EY
 
Jobmotor Mittelstand gerät ins Stocken
Jobmotor Mittelstand gerät ins Stocken Jobmotor Mittelstand gerät ins Stocken
Jobmotor Mittelstand gerät ins Stocken EY
 
Trotz Rekordumsätzen ist die Stimmung im Agribusiness durchwachsen
Trotz Rekordumsätzen ist die Stimmung im Agribusiness durchwachsenTrotz Rekordumsätzen ist die Stimmung im Agribusiness durchwachsen
Trotz Rekordumsätzen ist die Stimmung im Agribusiness durchwachsenEY
 
Rekordsummen für deutsche Start-ups
Rekordsummen für deutsche Start-upsRekordsummen für deutsche Start-ups
Rekordsummen für deutsche Start-upsEY
 

More from EY (20)

EY Price Point: global oil and gas market outlook, Q2 | April 2022
EY Price Point: global oil and gas market outlook, Q2 | April 2022EY Price Point: global oil and gas market outlook, Q2 | April 2022
EY Price Point: global oil and gas market outlook, Q2 | April 2022
 
EY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlookEY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlook
 
EY Price Point: global oil and gas market outlook, Q2 April 2021
EY Price Point: global oil and gas market outlook, Q2 April 2021EY Price Point: global oil and gas market outlook, Q2 April 2021
EY Price Point: global oil and gas market outlook, Q2 April 2021
 
Tax Alerte - Principales dispositions loi de finances 2021
Tax Alerte - Principales dispositions loi de finances 2021Tax Alerte - Principales dispositions loi de finances 2021
Tax Alerte - Principales dispositions loi de finances 2021
 
EY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlookEY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlook
 
Tax Alerte - prix de transfert - PLF 2021
Tax Alerte - prix de transfert - PLF 2021Tax Alerte - prix de transfert - PLF 2021
Tax Alerte - prix de transfert - PLF 2021
 
EY Price Point: global oil and gas market outlook (Q4, October 2020)
EY Price Point: global oil and gas market outlook (Q4, October 2020)EY Price Point: global oil and gas market outlook (Q4, October 2020)
EY Price Point: global oil and gas market outlook (Q4, October 2020)
 
EY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlookEY Price Point: global oil and gas market outlook
EY Price Point: global oil and gas market outlook
 
Zahl der Gewinnwarnungen steigt auf Rekordniveau
Zahl der Gewinnwarnungen steigt auf RekordniveauZahl der Gewinnwarnungen steigt auf Rekordniveau
Zahl der Gewinnwarnungen steigt auf Rekordniveau
 
Versicherer rechnen mit weniger Neugeschäft
Versicherer rechnen mit weniger NeugeschäftVersicherer rechnen mit weniger Neugeschäft
Versicherer rechnen mit weniger Neugeschäft
 
Liquidity for advanced manufacturing and automotive sectors in the face of Co...
Liquidity for advanced manufacturing and automotive sectors in the face of Co...Liquidity for advanced manufacturing and automotive sectors in the face of Co...
Liquidity for advanced manufacturing and automotive sectors in the face of Co...
 
IBOR transition: Opportunities and challenges for the asset management industry
IBOR transition: Opportunities and challenges for the asset management industryIBOR transition: Opportunities and challenges for the asset management industry
IBOR transition: Opportunities and challenges for the asset management industry
 
Fusionen und Übernahmen dürften nach der Krise zunehmen
Fusionen und Übernahmen dürften nach der Krise zunehmenFusionen und Übernahmen dürften nach der Krise zunehmen
Fusionen und Übernahmen dürften nach der Krise zunehmen
 
Start-ups: Absturz nach dem Boom?
Start-ups: Absturz nach dem Boom?Start-ups: Absturz nach dem Boom?
Start-ups: Absturz nach dem Boom?
 
EY Price Point: global oil and gas market outlook, Q2, April 2020
EY Price Point: global oil and gas market outlook, Q2, April 2020EY Price Point: global oil and gas market outlook, Q2, April 2020
EY Price Point: global oil and gas market outlook, Q2, April 2020
 
Riding the crest of digital health in APAC
Riding the crest of digital health in APACRiding the crest of digital health in APAC
Riding the crest of digital health in APAC
 
EY Chemical Market Outlook - February 2020
EY Chemical Market Outlook - February 2020EY Chemical Market Outlook - February 2020
EY Chemical Market Outlook - February 2020
 
Jobmotor Mittelstand gerät ins Stocken
Jobmotor Mittelstand gerät ins Stocken Jobmotor Mittelstand gerät ins Stocken
Jobmotor Mittelstand gerät ins Stocken
 
Trotz Rekordumsätzen ist die Stimmung im Agribusiness durchwachsen
Trotz Rekordumsätzen ist die Stimmung im Agribusiness durchwachsenTrotz Rekordumsätzen ist die Stimmung im Agribusiness durchwachsen
Trotz Rekordumsätzen ist die Stimmung im Agribusiness durchwachsen
 
Rekordsummen für deutsche Start-ups
Rekordsummen für deutsche Start-upsRekordsummen für deutsche Start-ups
Rekordsummen für deutsche Start-ups
 

Recently uploaded

CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHYCECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHYRMC
 
FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES 11
FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES  11FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES  11
FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES 11crzljavier
 
Hematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of HematinicsHematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of Hematinicsnetraangadi2
 
Experience the Power of Chiropractic in Maui
Experience the Power of Chiropractic in MauiExperience the Power of Chiropractic in Maui
Experience the Power of Chiropractic in MauiCentral Maui Chiropractic
 
ARTHRITIS.pptx Prepared by monika gopal Tutor
ARTHRITIS.pptx Prepared  by monika gopal TutorARTHRITIS.pptx Prepared  by monika gopal Tutor
ARTHRITIS.pptx Prepared by monika gopal TutorNehaKewat
 
Medical Malpractice & Medical Negligence (1).pptx
Medical Malpractice & Medical Negligence (1).pptxMedical Malpractice & Medical Negligence (1).pptx
Medical Malpractice & Medical Negligence (1).pptxanukshadias2
 
LARYNGEAL CANCER.pptx Prepared by Neha Kewat
LARYNGEAL CANCER.pptx  Prepared by Neha KewatLARYNGEAL CANCER.pptx  Prepared by Neha Kewat
LARYNGEAL CANCER.pptx Prepared by Neha KewatNehaKewat
 
Presentation on COUNSELING. 1ST YEAR GNM ,COMMUNITY HEALTH NURSING
Presentation on  COUNSELING. 1ST YEAR GNM ,COMMUNITY HEALTH NURSINGPresentation on  COUNSELING. 1ST YEAR GNM ,COMMUNITY HEALTH NURSING
Presentation on COUNSELING. 1ST YEAR GNM ,COMMUNITY HEALTH NURSINGKREDASONBANGALORE
 
Basics of Giant Cell Tumor of bone (GCTB)
Basics of Giant Cell Tumor of bone (GCTB)Basics of Giant Cell Tumor of bone (GCTB)
Basics of Giant Cell Tumor of bone (GCTB)bishwabandhuniraula
 
21 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 202421 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 2024Traumasoft LLC
 
Eating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports PsychologyEating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports Psychologyshantisphysio
 
Govt releases guidelines to curb unethical pharma sector practices.pdf
Govt releases guidelines to curb unethical pharma sector practices.pdfGovt releases guidelines to curb unethical pharma sector practices.pdf
Govt releases guidelines to curb unethical pharma sector practices.pdfCompetitionPedia
 
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, BenefitsArtificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, BenefitsIris Thiele Isip-Tan
 
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdf
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdfAnatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdf
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdfhezamzaki1
 
Introduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin BenefitsIntroduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin Benefitssahilgabhane29
 
Blood(The Applied Physiology) for Nurses.pptx
Blood(The Applied Physiology) for Nurses.pptxBlood(The Applied Physiology) for Nurses.pptx
Blood(The Applied Physiology) for Nurses.pptxNagamani Manjunath
 
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete HealthLiving Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete HealthLyons Health
 
ACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousKR_Barker
 

Recently uploaded (20)

CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHYCECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
CECT NECK NECK ANGIOGRAPHY CAROTID ANGIOGRAPHY
 
FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES 11
FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES  11FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES  11
FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES 11
 
Hematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of HematinicsHematinics and Erythropoietin- Pharmacology of Hematinics
Hematinics and Erythropoietin- Pharmacology of Hematinics
 
Experience the Power of Chiropractic in Maui
Experience the Power of Chiropractic in MauiExperience the Power of Chiropractic in Maui
Experience the Power of Chiropractic in Maui
 
The Power of Active listening - Tool in effective communication.pdf
The Power of Active listening - Tool in effective communication.pdfThe Power of Active listening - Tool in effective communication.pdf
The Power of Active listening - Tool in effective communication.pdf
 
ARTHRITIS.pptx Prepared by monika gopal Tutor
ARTHRITIS.pptx Prepared  by monika gopal TutorARTHRITIS.pptx Prepared  by monika gopal Tutor
ARTHRITIS.pptx Prepared by monika gopal Tutor
 
Medical Malpractice & Medical Negligence (1).pptx
Medical Malpractice & Medical Negligence (1).pptxMedical Malpractice & Medical Negligence (1).pptx
Medical Malpractice & Medical Negligence (1).pptx
 
LARYNGEAL CANCER.pptx Prepared by Neha Kewat
LARYNGEAL CANCER.pptx  Prepared by Neha KewatLARYNGEAL CANCER.pptx  Prepared by Neha Kewat
LARYNGEAL CANCER.pptx Prepared by Neha Kewat
 
Presentation on COUNSELING. 1ST YEAR GNM ,COMMUNITY HEALTH NURSING
Presentation on  COUNSELING. 1ST YEAR GNM ,COMMUNITY HEALTH NURSINGPresentation on  COUNSELING. 1ST YEAR GNM ,COMMUNITY HEALTH NURSING
Presentation on COUNSELING. 1ST YEAR GNM ,COMMUNITY HEALTH NURSING
 
Basics of Giant Cell Tumor of bone (GCTB)
Basics of Giant Cell Tumor of bone (GCTB)Basics of Giant Cell Tumor of bone (GCTB)
Basics of Giant Cell Tumor of bone (GCTB)
 
21 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 202421 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 2024
 
Eating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports PsychologyEating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports Psychology
 
Annual Training
Annual TrainingAnnual Training
Annual Training
 
Govt releases guidelines to curb unethical pharma sector practices.pdf
Govt releases guidelines to curb unethical pharma sector practices.pdfGovt releases guidelines to curb unethical pharma sector practices.pdf
Govt releases guidelines to curb unethical pharma sector practices.pdf
 
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, BenefitsArtificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
 
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdf
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdfAnatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdf
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdf
 
Introduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin BenefitsIntroduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin Benefits
 
Blood(The Applied Physiology) for Nurses.pptx
Blood(The Applied Physiology) for Nurses.pptxBlood(The Applied Physiology) for Nurses.pptx
Blood(The Applied Physiology) for Nurses.pptx
 
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete HealthLiving Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
 
ACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the Curious
 

The 2014 US biotech IPO market in 10 charts

  • 1. in 10 charts Among the 58 therapeutic companies ... The 2014 US biotech IPO market Therapeutic | 58 Diagnostic | 5 Licensed | 26% Q2 Q3 Q4 Therapeutic Molecular diagnostic Retained rights | 74% Of the 63 IPOs, over 92% were therapeutic companies US biotechs in 2014 not only set a record for number of IPOs ... ... but also set a record for IPO proceeds, nearing US$5 billion Only 31% of therapeutic companies were in Phase III or later By 31 December, stocks were up by 42% relative to their IPO prices … Nearly 60% were priced within or above their expected ranges ... while only 26% had licensed their lead product to a larger company 26+74+J Oncology | 14 CNS | 7 Infection | 6 Renal | 6 Endocrinology | 5 Ophthalmic | 5 Other | 15 24% were primarily in oncology ... 24+12+10+10+9+9+26+J Phase II | 32 Phase I | 5 Pre-clinical | 3 Marketed | 3 Phase III | 15 ... 55% were in Phase II ... 55+26+5+5+9+J H1 H2 Compiled by EY Global Life Sciences Center (@EY_LifeSciences) using data from 28 years of EY biotechnology annual reports. For more data, trends and implications, download our thought leadership at ey.com/lifesciences or join the conversation on our blog (lifesciencesblog.ey.com). 92+8+J Phase III or marketed Phase II or earlier Within or above Below range Q1 2000 52 412013 2005 17 282004 242006 222007 2014 63 2014 $4.9b 2000 $4.5b 2013 $3.3b 2004 $1.6b 2007 $1.2b 2006 $1.1b 2010 $1.1b Q2 Q3 Q4 34% 49% -33% 16% 70% 52% 43% 25%66% 75% 0% 0% 20% 20% -20% -40% 40% 40% 60% 60%80% … with therapeutic outperforming diagnostic Q1 73% 23 total IPOs 17 total IPOs 13 total IPOs 10 total IPOs 27% 38% 62% 54% 46% 60% 40%